Recent Finacing
Recent Raise
PhotoBiotics, an Imperial College London med‑tech spin‑out, develops biologically‑targeted photodynamic therapy agents (t‑PDT) for cancer—notably ProstaLite for prostate cancer—and MRI imaging agents, progressing toward preclinical and Phase I/II studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor